483
Elizabeth Arden, Inc.FDA 483 - Elizabeth Arden, Inc. - May 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Elizabeth Arden, Inc. in Salem, VA, a repacker of OTC drug products and cosmetics, revealed significant deficiencies in environmental controls. The firm failed to provide adequate equipment for humidity and temperature control, monitoring, and calibration in areas used for storing and packaging drug products. These issues raise concerns about the proper storage conditions for drug products.
Open in Dashboard
ID · d4246b7c-5b09-4961-9c3a-47d309986611